The Filgrastim Injection, cataloged under National Stock Number 6505-01-666-4875, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amgen Inc.. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-666-4875 |
| Primary Part Number | NEUPOGEN 30 MIO(0,3MG/ML) 5 AMP |
| Item Name | Filgrastim Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amgen Inc. |
| Status | ACTIVE |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NEUPOGEN 30 MIO(0,3MG/ML) 5 AMP PRIMARY | Amgen Inc. (USA) |
NSN 6505-01-666-4875 is a Filgrastim Injection, manufactured by Amgen Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-666-4875 has 1 manufacturer part number on file: NEUPOGEN 30 MIO(0,3MG/ML) 5 AMP (Amgen Inc.).
Key specifications for NEUPOGEN 30 MIO(0,3MG/ML) 5 AMP: Special Features: FILGRASTIM 0,3 MG/ML; Part Name Assigned by Controlling Agency: NEUPOGEN; Total Primary Container Quantity: 5. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.